Saffron: The Persian Antidepressant Elixir

The Remarkable Neuro-Psychological Benefits of Saffron (Crocus Sativus L.)

Saffron has always struck me as a curious and slightly mystical thing. A handful of crimson threads, light as air, and almost absurdly delicate. Its scent carries a particular nostalgia; its flavour announces itself in any dish; and its trade (bright, aromatic, and almost ceremonial) colours the markets of Iran and Iraq. Calling it a spice feels reductive, rude even. Every evening, my grandmother and aunties slip a few saffron threads into their evening tea and watch the water turn gold. They swear it helps them get to sleep, and on difficult days, helps them bear what had felt too heavy a few hours earlier. Turns out, as usual, the matriarchs of my family were seriously onto something.

Only later did I realise that this family folklore had a scientific counterpart: a field of research suggesting that saffron (Crocus sativus L.) may influence the brain and nervous system in remarkably clinical ways.

Mood Disorder

The most established and remarkable research concerns depression and anxiety. Across several randomised controlled trials, saffron has shown antidepressant effects that are superior to placebo and comparable or superior to standard SSRI medications such as fluoxetine and citalopram. A thorough meta-analysis drawing from multiple trials confirmed that saffron taken in doses around 30 mg/day reduced depressive symptoms to a degree statistically indistinguishable from these pharmaceuticals, but with fewer adverse side-effects.

Recent analyses deepen this picture. A 2022–2024 systematic review examining saffron’s effects on both depression and anxiety concluded that improvements were consistent across different populations and were accompanied by a relatively benign side-effect profile. Similarly, a 12-week randomised trial in adults with subclinical depressive symptoms found that saffron supplementation produced modest but real and significant improvements in depressive mood and sleep quality - not dramatic, but noticeable enough to matter in daily life.

So how does saffron do this?

Mechanistically, researchers have proposed several explanations. A 2024 review in Frontiers in Psychiatry highlighted saffron’s modulation of monoamine neurotransmitters, especially serotonin and dopamine, alongside its anti-inflammatory and antioxidant effects. This kind of modulation aligns with current medical understandings of depression as a condition shaped not only by neurotransmitter imbalance but also by chronic inflammation and oxidative stress.

Incredible.

Therefore, while saffron shouldn’t be seen as a replacement for clinical treatment in moderate or severe depression, there is a coherent and repeatable body of evidence suggesting benefit for people with mild to moderate symptoms or those seeking an adjunctive accessible option.

Cognitive Function and Neuroprotection

Saffron’s role in cognitive health is less well-known but perhaps even more fascinating. Several small but carefully conducted trials have examined its effects in mild cognitive impairment and early Alzheimer’s disease. In these studies, saffron improved cognitive test scores, such as ADAS-Cog and CDR-SB, and in some cases performed as well as standard medications traditionally prescribed for Alzheimer’s symptoms.

There is a basic understanding for why this might be happening. A recent investigation explored how compounds derived from saffron, in particular crocin and crocetin, might protect neurons under stress. The authors highlight evidence that these molecules can reduce oxidative stress, suppress inflammatory signalling, and mitigate neuronal damage triggered by harmful stimuli. These findings make sense when you look at the contemporary models for neurodegenerative diseases, in which chronic oxidative damage and neuroinflammation contribute to gradual neuronal loss and cognitive decline. Hence, saffron (or its active constituents) emerges not just as a mood-modulating spice but as an actual candidate for neuroprotective support, at least at the cellular and preclinical level.

It’s important to keep emphasising that this research remains in its infancy, but the direction is noteworthy: saffron appears not only to affect mood but also to exert subtler, longer-term effects on brain health itself.

ADHD and Behavioural Regulation

Among younger populations, saffron has shown promise in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). A clinical trial comparing saffron capsules to methylphenidate (Ritalin) found near-equivalent improvements in overall symptoms. Interestingly, the two treatments (saffron and methylphenidate) appeared to diverge in their strengths: saffron performed better on hyperactivity measures, while methylphenidate retained advantage on inattention.

Researchers have only begun to sketch why saffron might influence attentional and behavioural regulation, but several hypotheses recur. The most frequently cited once again involves monoaminergic modulation: compounds such as crocin and safranal appear to influence the availability or signalling of dopamine, norepinephrine, and serotonin, the very neurotransmitters central to ADHD pharmacology. Unlike the synthetic methylphenidate, which sharply increases synaptic dopamine and norepinephrine by blocking their reuptake, the natural saffron’s action here seems more subtle and regulatory, nudging these systems rather than forcing them upward.

This line of research is, again, still in its early-days, but it gestures toward a broader exciting potential.

Sexual Function & PMS

Saffron’s effects on sexual health and premenstrual symptoms form another, somewhat less discussed, area of evidence.

In a study of men who developed sexual dysfunction as a side effect of treatment with the antidepressant fluoxetine, saffron supplementation over a period of time restored aspects of libido and erectile function compared to placebo. Interestingly, while subjective and functional measures of sexual health improved, objective measures of semen quality (such as sperm count or motility) remained unchanged. This implies that saffron’s benefits in this context related more to desire, performance, and possibly psychological readiness, rather than to changes in sperm parameters.

There are some early stage studies suggesting similar results for women experiencing SSRI-induced sexual dysfunction with participants reporting significant improvements in sexual desire, arousal, vaginal lubrication, and overall sexual satisfaction compared to those receiving placebo.

Meanwhile, a study exposing women to saffron aroma for twenty minutes found reductions in salivary cortisol and anxiety, as well as reported reductions in premenstrual syndrome (PMS) symptoms compared to placebo across multiple measures, including emotional symptoms (like irritability and depression), physical complaints, and overall premenstrual discomfort. The authors concluded that saffron, likely via its bioactive constituents (crocin, crocetin, safranal, etc.), may help alleviate PMS symptoms, offering a safe, natural alternative to conventional treatments, at least for some women.

Saffron occupies a rare position in the world of natural compounds. It has profound cultural depth in the Middle East, particularly historic Persia. And although the data is still imperfect, it is undoubtedly a remarkable and indispensable product of the natural world. Those few crimson threads steeped in evening tea were more than comfort. They won’t replace antidepressants, halt dementia, or resolve complex disorders on their own. But they are not to be ignored.

Sometimes the simplest practices, steeped in tradition, hold truths that science can only stumble upon and begin to illuminate after the fact.

---

---

References

• Akhondzadeh, S., Fallah-Pour, H., Afkham, K., Jamshidi, A. H., & Khalighi-Cigaroudi, F. (2005). Comparison of Crocus sativus L. and fluoxetine in the treatment of mild to moderate depression: A randomized, double-blind pilot trial. Journal of Affective Disorders, 89(2–3), 163–169. https://pubmed.ncbi.nlm.nih.gov/15718057/

• Akhondzadeh, S., et al. (2010). Saffron in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial. Phytomedicine, 17(2), 130–133. https://doi.org/10.1016/j.phymed.2010.11.013

• Ayati, Z., Yang, G., Ayati, M. H., Emami, S. A., & Chang, D. (2020). Saffron for mild cognitive impairment and dementia: A systematic review and meta-analysis of randomised clinical trials. BMC Complementary Medicine and Therapies, 20(1), 333. https://doi.org/10.1186/s12906-020-03102-3

• Bahari, H., Shahraki Jazinaki, M., Aghakhani, L., Amini, M. R., Noushzadeh, Z., Khodashahi, R., & Malekahmadi, M. (2025). Crocin supplementation on inflammation and oxidative stress: A systematic review and meta-analysis. Phytotherapy Research, 39(1), 465–479. https://doi.org/10.1002/ptr.8380

• Blasco-Fontecilla, H., Moyano-Ramírez, E., Méndez-González, O., Rodrigo-Yanguas, M., Martin-Moratinos, M., & Bella-Fernández, M. (2022). Effectivity of saffron extract (Saffr’Activ) on treatment for children and adolescents with attention deficit/hyperactivity disorder (ADHD): A clinical effectivity study. Nutrients, 14(19), 4046. https://doi.org/10.3390/nu14194046

• Boskabady, M. H., et al. (2018). Crocus sativus in the treatment of ADHD: A pilot randomized trial. Phytotherapy Research, 32(12), 2447–2454. https://pubmed.ncbi.nlm.nih.gov/30154813/

• Fukui, H., Toyoshima, K., & Komaki, R. (2011). Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine, 18(8–9), 726–730. https://doi.org/10.1016/j.phymed.2010.11.013

• Hausenblas, H. A., Saha, D., Dubyak, P. J., & Anton, S. D. (2013). Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. https://pubmed.ncbi.nlm.nih.gov/24553745/

• Kianbakht, S., & Mozaffari, S. (2009). Clinical evaluation of Crocus sativus L. (saffron) on sexual dysfunction in men: A double-blind, placebo-controlled study. Phytomedicine, 16(12), 1025–1029. https://pubmed.ncbi.nlm.nih.gov/22552758/

• Levantin, A., et al. (2011). The effect of Crocus sativus L. on sexual dysfunction in women: A double-blind, randomized, placebo-controlled trial. Human Psychopharmacology, 26(6), 428–432. https://pubmed.ncbi.nlm.nih.gov/21242071/

• Lopresti, A. L., Smith, S. J., Marx, W., Díez-Municio, M., & Morán-Valero, M. I. (2025). An examination into the effects of a saffron extract (Affron) on mood and general wellbeing in adults experiencing low mood: A randomized, double-blind, placebo-controlled trial. The Journal of Nutrition, 155(7), 2300–2311. https://doi.org/10.1016/j.tjnut.2025.05.024

• Modabbernia, A., Sohrabi, H., Nasehi, M., et al. (2012). Efficacy and safety of Crocus sativus L. in the treatment of mild to moderate depression: A systematic review and meta-analysis. Journal of Affective Disorders, 148(2–3), 127–134. https://pubmed.ncbi.nlm.nih.gov/22552758/

• Modabbernia, A., Sohrabi, H., Nasehi, A. A., Raisi, F., Saroukhani, S., Jamshidi, A., Tabrizi, M., Ashrafi, M., & Akhondzadeh, S. (2012). Effect of saffron on fluoxetine-induced sexual impairment in men: Randomized double-blind placebo-controlled trial. Psychopharmacology, 223(4), 381–388. https://doi.org/10.1007/s00213-012-2729-6

• Picheta, N., Piekarz, J., Daniłowska, K., Mazur, K., Piecewicz-Szczęsna, H., & Smoleń, A. (2024). Phytochemicals in the treatment of patients with depression: A systemic review. Frontiers in Psychiatry, 15, 1509109. https://doi.org/10.3389/fpsyt.2024.1509109

• Rafieian-Kopaei, M., et al. (2019). Saffron in cognitive function and Alzheimer’s disease: Preclinical and clinical evidence. Journal of Ethnopharmacology, 231, 154–167. https://pubmed.ncbi.nlm.nih.gov/31451956/

• Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I., Rajai Firouz Abadi, S., Abhari, F. S., & Bakhtiyari, M. (2025). Effect of saffron versus selective serotonin reuptake inhibitors (SSRIs) in treatment of depression and anxiety: A meta-analysis of randomized controlled trials. Nutrition Reviews, 83(3), e751–e761. https://doi.org/10.1093/nutrit/nuae076

• Toshkani, F., et al. (2023). Neuroprotective mechanisms of Crocus sativus L. in cognitive disorders: A systematic review. Phytotherapy Research, 37(8), 3850–3864. https://pubmed.ncbi.nlm.nih.gov/39632602/

• Yang, X., Chen, X., Fu, Y., Luo, Q., Du, L., Qiu, H., Qiu, T., Zhang, L., & Meng, H. (2018). Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: A meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment, 14, 1297–1305. https://doi.org/10.2147/NDT.S157550